Seeking men and women with locally advanced pancreatic cancer that can't be completely removed with surgery for a study of an investigational drug added to the standard chemotherapy.
We are studying an investigational drug to reduce connective tissue growth factor (CTGF). Connective tissue growth factor (CTGF) is a protein naturally made in the body. If someone's body makes too much CTGF it may allow tumors to grow and spread. All study participants will receive the standard chemotherapy, but some will be randomly selected to also receive the investigational drug.
What we're hoping for
Evaluate whether adding an investigational drug to standard chemotherapy for locally advanced pancreatic cancer that can't be completely removed with surgery improves outcomes better than standard chemotherapy alone.
ClinicalTrials.gov Identifier: NCT03941093